Alberto Carletti - MolMed S Insider

MolMed S p A -- Germany Stock  

EUR 0.41  0.01  2.38%

Non-Executive Director

We currently do not have informatin regarding Alberto Carletti. This executive tanure with MolMed S p A is not currenlty determined.
Age: 56  Director Since 2012      

Management Efficiency

The company has return on total asset (ROA) of (18.1) % which means that it has lost $18.1 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (61.21) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 964 K in total debt with debt to equity ratio (D/E) of 6.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. MolMed S p A has Current Ratio of 1.37 which is within standard range for the sector.

Similar Executives

Showing few of many executives

DIRECTOR Since

W CornwellPfizer Inc
1997
Aida AlvarezWal Mart Stores Inc
2006
Fengchao ChengIndustrial and Commercial Bank
2015
Rongrong GeIndustrial and Commercial Bank
2012
Robson WaltonWal Mart Stores Inc
2015
Dingbang LiangIndustrial and Commercial Bank
2015
Frances FergussonPfizer Inc
2009
Helen HobbsPfizer Inc
2011
Gangcheng HuangIndustrial and Commercial Bank
2009
Zhongjun FuIndustrial and Commercial Bank
2013
Xiqun YiIndustrial and Commercial Bank
2013
Xiaoya WangIndustrial and Commercial Bank
2012
Don CornwellPfizer Inc
1997
Linda WolfWal Mart Stores Inc
2005
James SmithPfizer Inc
2014
Yongmiao HongIndustrial and Commercial Bank
2012
Thomas HortonWal Mart Stores Inc
2014
Ronald BlaylockPfizer Inc
2017
Qinghui KeIndustrial and Commercial Bank
2012
Steuart WaltonWal Mart Stores Inc
2016
James CashWal Mart Stores Inc
2013

Entity Summary

MolMed S p A (4HW) is traded on Frankfurt Stock Exchange in Germany. and employs 23 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add MolMed S p A to your portfolio

Top Management

MolMed S p Leadership Team
Gian Rizzardi, Director, Ph.D
Marina Bue, Director
Didier Trono, Director
Silvia Pisante, Executive
Mario Masciocchi, Director
Carlo Incerti, Director
Raffaella Ruggiero, Director
Holger Neecke, Director
Luca Alberici, Executive
Maurizio Tassi, Director
Daniele Pieraccioli, Director, Ph.D
Alberto Carletti, Director
Laura Ferro, Director
Marco Dieci, Director, Ph.D
Catia Traversari, Director, Ph.D
Lorenzo Salieri, Director
Elizabeth Robinson, Director
Riccardo Palmisano, CEO
Sabina Grossi, Director, Ph.D
Alfredo Messina, Director
Monica Masolo, Director
Germano Carganico, Executive, Ph.D
Claudio Bordignon, Chairman, Ph.D
Gianluigi Fiorendi, Director
Andrea Quaglino, Director
Khalid Islam, Director, Ph.D
Laura Villa, Director
Cynthia Giuliani, Director
Antonio Lambiase, Director, Ph.D
Marco Manoni, Director
Tiziano Andreoli, Director

Stock Performance

MolMed S Performance Indicators
Return On Equity(61.21) %
Return On Asset(18.1) %
Current Valuation195.6 M
Price to Earning(13.82) times
Price to Book11.53 times
Price to Sales9.28 times
Revenue22.42 M
Gross Profit1000 K
EBITDA(10.6 M)
Net Income(12.02 M)